Delivery Order SPE2DE24D0021-SPE2D626F55B3
- Not listed
- Fisher Scientific Company L.L.C. has been awarded a delivery order valued at $1,302.52 by the Department of Defense's Medical Supply Chain for the procurement of vaginal positive control solutions (6 x 0.9 mL units). The award, issued on December 10, 2025, with an ultimate completion date of December 17, 2025, operates under a fixed-price contract with economic price adjustment provisions and carries no set-aside designation. This delivery order represents a child award under a larger indefinite...
- Fisher Scientific Company L.L.C., a major federal vendor specializing in laboratory and medical supplies, received a delivery order valued at $6,450.30 from the Department of Defense's Medical Supply Chain for vaginal positive control material (6 units of 0.9 milliliters each). The award, issued on December 5, 2025, with an ultimate completion date of December 12, 2025, is structured as a fixed-price contract with economic price adjustment provisions. The contract involves no small business...
- Fisher Scientific Company L.L.C. has been awarded a delivery order valued at $1,302.52 by the Department of Defense's Medical Supply Chain for vaginal position control product (6 units at 0.9 milliliters each). The award was made on December 17, 2025, with an ultimate completion date of December 24, 2025. This delivery order operates under a fixed-price contract with economic price adjustment terms and carries no set-aside designation, indicating it was awarded through open competition....
- Fisher Scientific Company L.L.C. has been awarded a delivery order valued at $3,394.40 by the Department of Defense's Medical Supply Chain for the provision of vaginal positive control solutions (6 x 0.9 mL per unit). The contract, awarded on September 11, 2025, carries a fixed-price structure with economic price adjustment provisions and is scheduled for ultimate completion by September 18, 2025. Performance will take place in Pittsburgh, Pennsylvania. This delivery order represents a child...
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $1,425.78 on August 13, 2025, for the procurement of vaginal negative control specimens (6 x 0.9 milliliter each). This fixed-price contract with economic price adjustment will be performed in Pittsburgh, Pennsylvania, with an ultimate completion date of August 20, 2025. The award was made without a set-aside designation, reflecting Fisher Scientific's competitive standing in open federal procurement. The funding agency is...
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $1,953.78 by the Defense Medical Supply Chain on August 14, 2025, for the supply of vaginal positive control material in 6x0.9ml units. The contract, which employs fixed-price pricing with economic price adjustment terms, carries a completion date of August 21, 2025, and will be performed in Pittsburgh, Pennsylvania. This award represents a child contract under a larger vehicle and was made through open competition with no...
- Fisher Scientific Company L.L.C. has been awarded a delivery order valued at $1,540.15 for vaginal positive control material (6 units of 0.9 milliliters each) by the Medical Supply Chain, a defense-focused federal agency. The contract, awarded on September 15, 2025, is structured as a fixed-price delivery order with economic price adjustment provisions and is scheduled for ultimate completion by September 22, 2025. The award represents an open competition procurement with no set-aside...
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $1,112.82 on September 4, 2025, for the supply of vaginal negative control specimens (6 units at 0.9 milliliters each) to support federal medical supply chain operations. The contract is structured as a fixed-price delivery order with economic price adjustment provisions and does not utilize a set-aside designation, indicating open competition. The place of performance is Pittsburgh, Pennsylvania, with an ultimate completion...
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $2,491.98 on August 6, 2025, for the supply of vaginal positive control material (6 units at 0.9 milliliters each). This fixed-price contract with economic price adjustment provisions is scheduled for completion by August 13, 2025, and will be performed in Pittsburgh, Pennsylvania. The contract was awarded by the Defense Medical Supply Chain, a defense-focused federal agency supporting military and related healthcare...
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $4,154.16 by the Department of Defense's Medical Supply Chain on August 6, 2025, for the procurement of vaginal positive control material (6 units at 0.9 milliliters each). This fixed-price delivery order with economic price adjustment authority is scheduled for ultimate completion by August 13, 2025, with performance to be fulfilled in Pittsburgh, Pennsylvania. The contract was awarded through open competition with no...
- SPE2DE24D0021Indefinite Delivery Contract
- SPE2DE24D0021-SPE2D626F55B3Delivery Order
Fisher Scientific Company L.L.C. was awarded a delivery order by the Department of Defense's Medical Supply Chain for vaginal negative control specimens (6 packs at 0.9 milliliters each) on December 23, 2025, with a ceiling value of $1,276.17. This is a fixed-price contract with economic price adjustment provisions, with performance to be completed by December 23, 2025 at the contractor's location in Pittsburgh, Pennsylvania. No set-aside designation was applied to this award, indicating open competition. This delivery order represents a routine procurement of diagnostic quality control materials supporting clinical laboratory operations across the Department of Defense's medical facilities. This award is issued as a child contract under a larger procurement vehicle, reflecting Fisher Scientific's established role as a critical federal supplier of laboratory equipment, diagnostic test kits, and medical supplies to the Department of Defense and other federal agencies. Fisher Scientific maintains a substantial contract portfolio with the Department of Veterans Affairs and other federal health agencies, demonstrating proven capability in delivering specialized laboratory reagents and diagnostic supplies. The modest individual award value is consistent with the company's role in providing consumable supplies on an as-needed basis through established contracting mechanisms, supporting the Department of Defense's medical supply chain operations and broader diagnostic laboratory capabilities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 12/22/25 |